NALLY MICHAEL

PrivateCIK: 1763945
Location

PITTSBURGH, PA

NALLY MICHAEL enters GENERATE BIOMEDICINES, INC. with 2.21M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Indirect Derivatives
InsiderNALLY MICHAELCIK 1763945
DirectorOfficer· Chief Executive Officer
Since Mar 2026
2.21M
Baseline shares
25% direct
552.71K
Direct ownership
1 position
5.57M
Derivative underlying
7 instruments
3
Security positions
1.66M indirect
Non-Derivative Holdings3

Common Stock

Indirect
Shares owned658.33K

Common Stock

Direct
Shares owned552.71K

Common Stock

Indirect
Shares owned999.79K
Total
552.71K direct·1.66M indirect2.21M
Derivative Holdings7

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

658.33K

Shares owned

N/A

Exercise price

9.15

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

2.21M

Shares owned

N/A

Exercise price

0.34

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

572.75K

Shares owned

N/A

Exercise price

7.19

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

315.83K

Shares owned

N/A

Exercise price

0.34

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

631.66K

Shares owned

N/A

Exercise price

0.34

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

526.66K

Shares owned

N/A

Exercise price

7.25

Expiration

Exercise window

Series A Preferred Stock

Indirect
Underlying security
Common Stock

Underlying shares

658.33K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Total

Underlying

5.57M

Owned

0.00

NALLY MICHAEL — Initial Ownership Disclosure (Form 3) Filed Feb 26, 2026 | Finecho